Invivyd Statistics
NASDAQ: IVVDHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
0.4127-0.0332 (-7.45%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Invivyd by the numbers
Invivyd has a market capitalization of $122.0 million based on 295.63M shares outstanding. With trailing EPS of $-0.38, Invivyd is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 40.1% below its 50-day average and 60.8% below its 200-day average.
Average daily trading volume is 5.20M shares, or about $2.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IVVD valuation vs. peer median
| Metric | IVVD | Peer median | Difference |
|---|---|---|---|
| Market cap | $122.01M | $120.17M | +2% |
| Avg. volume | 5.20M | 1.16M | +349% |
Peer median across 8 companies: HUMA, CMPX, ENGN, ARMP, FATE, CRDL, TARA, STRO.
Valuation
- Market cap
- $122.01M
- Price / sales (latest FY)
- 2.28
- EPS (TTM)
- $-0.38
- Shares outstanding
- 295.63M
Price and trading
- Previous close
- 0.4459
- Open
- 0.4401
- Day range
- 0.4127 – 0.4669
- 52-week range
- 0.4127 – 3.01
- 52-week change
- -83.49%
- 50-day moving average
- 0.6887
- Beta
- —
- Volume
- 5.30M
- Average volume
- 5.20M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 122.01M
- Forward Pe
- -0.75
- Eps
- -0.38
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.01
- Week52 Low
- 0.41
- Avg Volume
- 5.20M
- Shares Outstanding
- 295.63M
- Ma50
- 0.69
- Ma200
- 1.05
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -86.29%
- Pct From52w Low
- 0.00%